IL6 and depressive disorder: Over one-third of patients treated with interferon alpha develop significant depressive symptoms and anhedonia [12, 13] and several studies and meta-analyses have reported an association between depression and increased circulating levels of pro-inflammatory cytokines, most consistently interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) [14–16].